Search results
Results From The WOW.Com Content Network
Ferozsons (Pvt) Limited (also Ferozsons Publishers) ( Urdu: فیروزسنز) is a Pakistani publishing company in Lahore, Pakistan. Established in 1894, it is Pakistan’s oldest publishing house. In 1954, the Ferozsons Business Group expanded when one of the family members founded Ferozsons Laboratories, one of Pakistan’s first ...
Sanofi was founded in 1973 [5] as a subsidiary of Elf Aquitaine (a French oil company subsequently acquired by Total), when Elf Aquitaine took control of the Labaz group, a pharmaceutical company formed in 1947 by Sociéte Belge de l'Azote et des Produits Chimiques du Marly; [6] Labaz developed benziodarone in 1957.
Bausch Health Companies Inc. (formerly Valeant Pharmaceuticals International, Inc.) is an American-Canadian multinational specialty pharmaceutical company based in Laval, Quebec, Canada. It develops, manufactures and markets pharmaceutical products and branded generic drugs , primarily for skin diseases , gastrointestinal disorders , eye health ...
Valeant Pharmaceuticals (NYS: VRX) announced plans on Monday to acquire Medicis Pharmaceutical (NYS: MRX) for $2.6 billion. The deal values Medicis at a 39% premium to Friday's closing price.
Martin Dow is a Pakistani multinational pharmaceutical company which is based in Karachi, Pakistan. It was founded in 1995 [3] and is one of the leading pharmaceutical companies in Pakistan. It has more than 60 brands and over 1000 employees. Its products are manufactured in Karachi at its cGMP compliant manufacturing plant.
An agricultural company made the surprise decision Tuesday to cancel a project to build a massive grain terminal in a historic Black town in Louisiana's “Cancer Alley," a heavily industrialized ...
July 30, 2024 at 6:52 AM. (Reuters) - COVID-19 vaccine maker BioNTech's cancer drug candidate BNT111 showed significant improvement in the response rate in patients with advanced melanoma during a ...
The pharmaceutical industry in Pakistan was estimated to be worth Rs. 748 billion (US$2.6 billion) in 2023, representing about 1% of the country's GDP. [1] The industry is largely import-dependent, with more than 90% of raw material being imported and only 12% of APIs locally produced. [1] Pakistani pharmaceutical companies are engaged in ...